Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1 ML Leuprolide Acetate 7.5 MG/ML Prefilled Syringe [Lupron]

Known as: 1 ML Lupron 7.5 MG/ML Prefilled Syringe, Lupron Depot 7.5 MG per 1 ML (1 month) Prefilled Syringe, Lupron Depot-Ped 7.5 MG per 1 ML (1 month) Prefilled Syringe 
 
National Institutes of Health

Related topics

Related topics

28 relations
1 ML Leuprolide Acetate 11.25 MG/ML Prefilled Syringe [Lupron]1 ML Leuprolide Acetate 15 MG/ML Prefilled Syringe [Lupron]1.5 ML Leuprolide Acetate 20 MG/ML Prefilled Syringe [Lupron]1.5 ML Leuprolide Acetate 7.5 MG/ML Prefilled Syringe [Lupron]
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Reverse Engineering the 1-Month Lupron Depot®
The 1-month Lupron Depot® (LD) encapsulating water-soluble leuprolide in poly(lactic-co-glycolic acid) (PLGA) microspheres is a… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose…
To test the efficacy and safety of leuprolide acetate (Lupron Depot) in the treatment of Alzheimer's disease (AD), we conducted a… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?
2011
2011
LUPRON DEPOT® -3 Month 11.25 mg (leuprolide acetate for depot suspension) 3-MONTH FORMULATION
  • LUPRON DEPOT
  • 2011
    • Corpus ID: 11081589
Leuprolide acetate is a long-acting GnRH analog. A single injection of LUPRON DEPOT–3 Month 11.25 mg will result in an initial… Expand
  • figure 3
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
2001
2001
Lupron Depot Prevention of Antispermatogenic/Antifertility Activity of the Indenopyridine, CDB-4022, in the Rat1
Abstract The goals of this study were to determine the CDB-4022 dose-response relationship for induction of acute decreases in… Expand
Is this relevant?
1998
1998
Effect of Leuprolide Acetate in Treatment of Abdominal Pain and Nausea in Premenopausal Women with Functional Bowel Disease: A Double-Blind, Placebo-Controlled, Randomized Study
We have previously reported impressive results in using a gonadotropin-releasing hormone analog, leuprolide acetate (Lupron), in… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys.
Several investigators have demonstrated that LHRH agonists (LHRHa) inhibit ovarian follicular depletion induced by… Expand
Is this relevant?
1994
1994
Sex Hormones Regulate ABR Latency
In an effort to characterize more completely the influence of sex hormones on auditory brainstem response (ABR) latency, we… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1993
1993
Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
OBJECTIVE To assess the efficacy and safety of a long-acting gonadotropin-releasing hormone analogue (GnRHa), leuprolide acetate… Expand
Is this relevant?
1992
1992
Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
We report results from 2 years of therapy with the long-acting form of the gonadotropin-releasing hormone (GnRH) analog… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group.
The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE